CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Xeris Biopharma - CapyFin

Xeris Biopharma

XERS · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $46.5M

Previous year: -$0.1

Total Revenue Growth YoY

Recorlev Revenue Growth YoY

Recorlev Patient Increase

Cash and Equivalents

Previous year: $57.6M

Previous year: $332M

Loading...

Key Statistics

Market Cap

$1.22B

P/E Ratio

-32.97

Sector

N/A

Industry

N/A

52-Week High

$9.89

52-Week Low

$3.54

Total Revenue Growth YoY

48.8%

Recorlev Revenue Growth YoY

135.7%

Recorlev Patient Increase

122%

Gvoke Prescription Growth

5%

COGS Increase YoY

53%

Xeris Biopharma

Unlock previous datapoints

Xeris Biopharma

Unlock previous datapoints

Xeris Biopharma Revenue by Segment

Revenue by Segment

Recorlev Revenue

Unlock previous datapoints

CapyFin.com

Gvoke Revenue

Unlock previous datapoints

CapyFin.com

Keveyis Revenue

Unlock previous datapoints

CapyFin.com

Other Product Revenue

CapyFin.com

Royalty, Contract & Other Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...